drugs, carbamazepine, and steroids were ineffective. He also underwent 2 dental extractions without relief of his symptoms. The patient had no medical or family history of headache disorders including migraines. Results of his neurological examination were unremarkable except for a left-sided hypesthesia in the maxillary division of the trigeminal nerve (V2).
Imaging Findings. The patient was referred to our institution after CT imaging showed a left-sided CPA hypodensity with mild mass effect near the pons and exiting cranial nerves. An MRI study revealed a mass next to the left ventrolateral pons that measured approximately 3.1 cm in the anteroposterior direction. The mass extended from the ambient cistern to the Meckel cave, causing upward displacement of the left trigeminal nerve and the 7th-8th cranial nerve complex. The mass was hypointense to gray matter on T1-weighted, hyperintense on T2-weighted, and heterogeneous on FLAIR sequences. The lesion exhibited restriction on DW imaging, with corresponding dropout on apparent diffusion coefficient mapping. These imaging features were suggestive of an epidermoid tumor (Fig. 1) .
Operation. The patient underwent a left retrosigmoid craniotomy for resection of the CPA lesion (Video 1). The mass was soft and pearly white, consistent with an epidermoid cyst. There was significant compression of the 5th-10th cranial nerves (Fig. 2) . The tumor was removed in a piecemeal fashion, and we were able to achieve a gross-total resection.
Postoperative Course. The postoperative MRI showed a gross-total resection with no residual diffusion restriction (Fig. 3) . Pathological examination confirmed the diagnosis of an epidermoid tumor. The patient reported complete resolution of his facial pain and no longer experienced any signs or symptoms of SUNCT. Postoperatively he exhibited a mild 6th nerve palsy and numbness of the mandibular division of the trigeminal nerve (V3) on the left, both of which resolved by 2 weeks. The patient's pain medications were gradually discontinued, and he remained symptom free without medications at his 6-month follow-up.
Discussion
The SUNCT syndrome is considered a subset of short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms. The syndrome is classified under the TACs, a group that includes cluster headaches and paroxysmal hemicranias. The TACs are characterized by unilateral pain in the trigeminal nerve distribution that is associated with ipsilateral cranial autonomic symptoms. 5 The underlying pathophysiology in this group arises from the activation of the trigeminal system with disinhibition of the trigeminofacial reflex.
9,10
Functional MRI studies show ipsilateral hypothalamic activation, suggesting a relationship with pain-modulating and autonomic systems. 8, 10 Headache disorders are grouped according to pain intensity, response to therapy, severity of autonomic symptoms, attack frequency, and duration of the attacks. 3 Among the TACs, the SUNCT syndrome has the shortest duration and highest frequency of attacks. The SUNCT syndrome is more common in males, and the mean age at onset (in both sexes) is approximately 50 years. 10 Attacks last 2-600 seconds, with a mean length of roughly 1 minute. 2, 5, 10 Attacks lasting longer than 240 seconds often comprise closely grouped stabs or saw-tooth attacks.
2 Attack frequency may range from a single episode to hundreds per day. Some patients have so many attacks that they are unable to quantify the actual number. 2, 10 The most common differential diagnosis of SUNCT is trigeminal neuralgia. 3 Both SUNCT syndrome and trigeminal neuralgia are short-lasting, exhibit cutaneous triggers, and present with lancinating pain associated with autonomic symptoms in the trigeminal distribu- tion.
2,11 However, unlike SUNCT syndrome, trigeminal neuralgia has milder autonomic symptoms and usually responds to carbamazepine. 4 Our patient fulfilled all the diagnostic criteria for SUNCT (Table 1) ; experienced significant autonomic symptoms including conjunctival injection, lacrimation, and nasal congestion; and failed to respond to carbamazepine. 5 The SUNCT syndrome is primarily idiopathic but has been reported in conjunction with a variety of intracranial lesions including pituitary tumors, arteriovenous malformations, cavernous hemangiomas, HIV/AIDS posterior fossa lesions, meningiomas, vascular compression of the trigeminal nerve, and osseous lesions of the posterior fossa.
1,2,7,10,12,14 Criteria have been proposed for establishing a causal relationship in a patient with a lesion and a headache disorder (Table 2) . 12 In the case reviewed here, all the criteria were met for establishing a causal link between the epidermoid tumor and SUNCT syndrome. To our knowledge this is the first case of SUNCT secondary to an epidermoid tumor in the CPA in which there was resolution of symptoms after a retrosigmoid craniotomy and resection. A case of short-lasting unilateral neuralgiform headache attacks with cranial autonomic symptoms attributed to an epidermoid cyst in the right CPA and treated successfully with surgery was recently reported. 6 Our case fulfills the full criteria for SUNCT with resolution after resection.
Idiopathic SUNCT syndrome is clinically indistinguishable from SUNCT syndrome caused by a structural lesion. Neuroimaging should be considered in all TAC or TAC-like disorders, especially when atypical signs or symptoms are present. 13 Our patient presented with trigeminal hypesthesia and dysphagia, both uncommon findings in SUNCT syndrome.
Conclusions
The SUNCT syndrome is a rare headache disorder that is infrequently associated with secondary intracranial lesions, with few reports of successful neurosurgical intervention. To our knowledge this is the first case of SUNCT secondary to an epidermoid tumor in the CPA in which there was resolution of symptoms after a retrosigmoid craniotomy and resection. This case demonstrates the importance of early MRI studies in the workup and treatment of SUNCT.
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